-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Neurocrine Biosciences Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q1 2024.
- Neurocrine Biosciences Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was $130M.
- Neurocrine Biosciences Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was $390M, a 14.9% increase from 2022.
- Neurocrine Biosciences Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was $339M, a 32.3% increase from 2021.
- Neurocrine Biosciences Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was $257M, a 12.3% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)